MFBTD
BMRN icon

MB Financial Bank - Trust Department’s BioMarin Pharmaceuticals BMRN Stock Holding History

MB Financial Bank - Trust Department’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-101
Closed -$6K – 455
2014
Q3 		$6K Hold
101
– – ﹤0.01% 515
2014
Q2 		$6K Buy
+101
New +$6.1K ﹤0.01% 473

Other funds holding BMRN

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

MB Financial Bank - Trust Department's BMRN Position: Q4 2014 in Review

MB Financial Bank - Trust Department sold out of BioMarin Pharmaceuticals (BMRN) in Q4 2014, closing a stake of 101 shares — an estimated $6K sold.

MB Financial Bank - Trust Department first reported a position in BMRN in Q2 2014 and held it in 2 quarters. The position peaked at $6K in Q3 2014. 342 funds tracked by Wall St. Rank hold BMRN as of Q4 2014.

  • MB Financial Bank - Trust Department reported no remaining BioMarin Pharmaceuticals position as of Q4 2014 after selling out during the quarter.
  • MB Financial Bank - Trust Department sold 101 BioMarin Pharmaceuticals shares in Q4 2014, an estimated $6K.
  • MB Financial Bank - Trust Department first reported a position in BioMarin Pharmaceuticals in Q2 2014 and held it in 2 quarters.
  • MB Financial Bank - Trust Department's BioMarin Pharmaceuticals position peaked at $6K in Q3 2014.
  • 342 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q4 2014.

Based on MB Financial Bank - Trust Department's 13F filing for Q4 2014, filed 22 Jan 2015.